Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SRD441 Ointment in Atopic Dermatitis
NCT00882245Phase 2Completed
- Sponsor
- Serentis
- Start
- Apr 2009
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of SRD-441 in atopic dermatitis (AD), sponsored by Serentis. Started Apr 2009; status: completed.
02
Drugs
SRD-441
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00882245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00882245.